Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $3.7 million.

  • Rallybio's Accumulated Expenses fell 4050.01% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 4050.01%. This contributed to the annual value of $5.0 million for FY2024, which is 3849.78% down from last year.
  • According to the latest figures from Q3 2025, Rallybio's Accumulated Expenses is $3.7 million, which was down 4050.01% from $4.2 million recorded in Q2 2025.
  • Rallybio's Accumulated Expenses' 5-year high stood at $9.5 million during Q2 2024, with a 5-year trough of $2.5 million in Q1 2025.
  • In the last 3 years, Rallybio's Accumulated Expenses had a median value of $6.3 million in 2024 and averaged $6.4 million.
  • Per our database at Business Quant, Rallybio's Accumulated Expenses skyrocketed by 6136.4% in 2024 and then tumbled by 7289.47% in 2025.
  • Over the past 3 years, Rallybio's Accumulated Expenses (Quarter) stood at $8.1 million in 2023, then plummeted by 38.5% to $5.0 million in 2024, then dropped by 24.71% to $3.7 million in 2025.
  • Its Accumulated Expenses stands at $3.7 million for Q3 2025, versus $4.2 million for Q2 2025 and $2.5 million for Q1 2025.